We focus in three core areas that are growing rapidly and have limited competition from other investors. Market & Investment Focus Clinical development and drug discovery Our focus is on making it cheaper to identify and bring treatments to those who need them most. Cellular and Gene and drug discovery Therapies We intend to invest in promising therapeutics that could, in turn, benefit from our development platform. Patient Management and Digital Health We also have an interest in companion software and applications, given its potential to reduce potential to reduce healthcare costs in the U.S. by $7B+ per annum. We invest in early-stage treatments and technology that reduce costs and improve outcomes.